Abstract:Abstract Purpose/Objective(s): Lung cancer is the leading cause of cancer deaths in the United States and worldwide. There has been little improvement in survival over the past several decades and surgery is generally considered to be the only curative treatment. We, therefore, performed a genome-wide functional genomics screen on human lung adenocarcinoma cells to identify genes involved in chemo- and radiotherapy resistance. Based on these results, we hypothesized that serine hydroxymethyltransferase-2 (SHMT2), which catalyzes the conversion of serine to glycine, is a target for chemoradiotherapy resistance in preclinical models of lung adenocarcinoma. Materials/Methods: PC9 cells were treated three times with 1 uM cisplatin and 2 Gy radiation before being subjected to genomic, untargeted metabolomic, or proteomic analysis. For the genomic analysis, PC9 cells were transfected with an shRNA viral library containing ~60,000 individual shRNAs following treatment. shRNAs that were depleted were hypothesized to represent genes involved in chemo-/radioresistance. Proteomics analysis was conducted after treatment and quantified by tandem mass tags isobaric labeling, totaling ~2,100 quantifiable proteins. An untargeted metabolomics approach was conducted after treatment, using gas chromatography mass spectrometry to quantify ~95 metabolites. Protein expression following treatment was determined by Western blot. Potential drug targets were assessed via colony formation assays. The Cancer Genome Atlas (TCGA) was queried to confirm in vivo human clinical correlations. Results: Our genomic, proteomic, and metabolomics screens indicated glutathione detoxification and oxidative stress response were major compensatory pathways upregulated after cisplatin and radiation treatment. We validated three targets, SLC7A11, GPX4, and SHMT2, as genes involved in chemo-radioresistance in vitro. The respective small molecule inhibitors of these gene targets, IKE, RSL3, and SHIN1, were synergistic when combined with cisplatin and radiation. SHIN1 appeared to also induce oxidative stress through ferroptosis, although this mechanism of cell death must be interrogated further. Analysis of TCGA revealed SHMT2 expression is upregulated in human lung adenocarcinoma in vivo and that higher expression is associated with decreased overall and disease-free survival. Conclusion: SHMT2 was identified as a novel target to overcome treatment resistance in human lung adenocarcinoma, which may be regulated ferroptotic cell death. Citation Format: Kunal R. Chaudhary, Connor J. Kinslow, Ling F. Ye, Pavan S. Upadhyayula, Eun Y. Lee, Ramon C. Sun, Simon K. Cheng. Serine hydroxymethyltransferase-2 as regulator of oxidative stress and chemoradiation resistance in lung adenocarcinoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 1992.

Global profiling of transcriptome, proteome and 2-hydroxyisobutyrylome in radioresistant lung adenocarcinoma cell

Prognostic Biomarkers after Radiotherapy for Nonsmall Cell Lung Cancer Based on Bioinformatics Analysis

Targeting Nrf2/PHKG2 Axis to Enhance Radiosensitivity in NSCLC.

Genome-wide Global Identification of NRF2 Binding Sites in A549 Non-Small Cell Lung Cancer Cells by ChIP-Seq Reveals NRF2 Regulation of Genes Involved in Focal Adhesion Pathways

Profiling Global Kinome Signatures of the Radioresistant MCF-7/C6 Breast Cancer Cells Using MRM-based Targeted Proteomics

Comparative Proteomic Analysis of Irradiation-Induced Radioresistant Breast Cancer Cells Using Label-Free Quantitation

Properties and Gene Expression Profiling of Acquired Radioresistance in Mouse Breast Cancer Cells.

Comparative Proteomic and Radiobiological Analyses in Human Lung Adenocarcinoma Cells

Radiosensitivity-Specific Proteomic and Signaling Pathway Network of Non-Small Cell Lung Cancer (NSCLC).

Molecular mechanism of radiation tolerance in lung adenocarcinoma cells using single‐cell RNA sequencing

Characterization and Mechanisms of Radioresistant Lung Squamous Cell Carcinoma Cell Lines

TGM2-Mediated Autophagy Contributes to the Radio-Resistance of Non-Small Cell Lung Cancer Stem-like Cells

Time-course differential lncRNA and mRNA expressions in radioresistant hypopharyngeal cancer cells.

Serine hydroxymethyltransferase-2 as regulator of oxidative stress and chemoradiation resistance in lung adenocarcinoma.

The Impact of Radioresistant-Related Telomere Genes in the Prognosis and Immune Infiltration in Lung Adenocarcinoma

Multiomics Differences in Lung Squamous Cell Carcinoma Patients with High Radiosensitivity Index Compared with Those with Low Radiosensitivity Index

Gene expression profiling of a radioresistant esophageal squamous cancer cell line

Suppresses of LIM Kinase 2 Promotes Radiosensitivity in Radioresistant Non-Small Cell Lung Cancer Cells

Comprehensive analysis of key genes and microRNAs in radioresistant nasopharyngeal carcinoma

Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma

Lung adenocarcinoma radiosensitivity depends on EGFR signaling pathway or other pathways? —— a research based on gene sequencing and data-independent acquisition (DIA) mass spectrometry